Chemoinformaics analysis of 2-(3-METHYLBUT-2-ENYL)NAPHTHALENE-1,4-DIONE
| Molecular Weight | 226.275 | nRot | 2 |
| Heavy Atom Molecular Weight | 212.163 | nRig | 12 |
| Exact Molecular Weight | 226.099 | nRing | 2 |
| Solubility: LogS | -4.654 | nHRing | 0 |
| Solubility: LogP | 3.986 | No. of Aliphatic Rings | 1 |
| Acid Count | 0 | No. of Aromatic Rings | 1 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 1 |
| Atoms Count | 31 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 17 | No. of Aromatic Carbocycles | 1 |
| nHetero | 2 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 14 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 15 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 6 |
| No. of Oxygen atom | 2 | No. of Arom Bond | 6 |
| nHA | 2 | APOL | 35.9891 |
| nHD | 0 | BPOL | 15.7809 |
| QED | 0.669 |
| Synth | 3.854 |
| Natural Product Likeliness | 3.253 |
| NR-PPAR-gamma | 0.004 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Accepted |
| Golden Triangle | Accepted |
| Pgp-inh | 0.005 |
| Pgp-sub | 0 |
| HIA | 0.003 |
| CACO-2 | -4.538 |
| MDCK | 0.0000136 |
| BBB | 0.978 |
| PPB | 0.744252 |
| VDSS | 0.953 |
| FU | 0.321177 |
| CYP1A2-inh | 0.149 |
| CYP1A2-sub | 0.518 |
| CYP2c19-inh | 0.095 |
| CYP2c19-sub | 0.852 |
| CYP2c9-inh | 0.276 |
| CYP2c9-sub | 0.681 |
| CYP2d6-inh | 0.007 |
| CYP2d6-sub | 0.865 |
| CYP3a4-inh | 0.055 |
| CYP3a4-sub | 0.231 |
| CL | 8.772 |
| T12 | 0.122 |
| hERG | 0.006 |
| Ames | 0.019 |
| ROA | 0.078 |
| SkinSen | 0.076 |
| Carcinogencity | 0.029 |
| EI | 0.833 |
| Respiratory | 0.871 |
| NR-Aromatase | 0.02 |
| Antiviral | Yes |
| Prediction | 0.624693 |